Société Générale — M&A Activity 2020

Apr 21, 2020

National Storage Mechanism | Additional information

RNS Number : 3328K

Societe Generale SA

21 April 2020

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1.       KEY INFORMATION

Name of person dealing (Note 1)	Société Générale S.A.
Company dealt in	Allergan plc
Class of relevant security to which the dealings being disclosed relate (Note 2)	US$0.0001 ordinary shares
Date of dealing	20/04/2020

2.         INTERESTS AND SHORT POSITIONS

(a)        Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

	Long		Short
Number	(%)	Number	(%)
(1) Relevant securities	2,979,032	0.91	45,401	0.01
(2) Derivatives (other than options)	0	0.00	1,855,513	0.56
(3) Options and agreements to purchase/sell	58,500	0.02	0	0.00
Total	*5,343,186	*1.62	1,900,914	0.58

* Include the holding of 2,305,654 shares on borrow products

(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1.       DEALINGS (Note 4)

(a)      Purchases and sales

Purchase/sale	Number of relevant securities	Price per unit USD (Note 5)
Purchase	100	187.07
Purchase	80	187.05
Purchase	100	188.33
Purchase	100	187.81
Purchase	100	187.86
Purchase	100	187.8
Purchase	100	187.81
Purchase	32	187.9
Purchase	100	187.94
Purchase	100	187.85
Purchase	98	187.66
Purchase	100	187.75
Purchase	93	188.6
Purchase	1	188.6
Purchase	100	188.51
Purchase	100	188.18
Purchase	100	187.89
Purchase	100	187.8
Purchase	100	188.15
Purchase	100	187.75
Purchase	100	187.96
Purchase	100	188.21
Purchase	100	187.82
Purchase	98	187.53
Purchase	2	187.53
Purchase	100	187.49
Purchase	50	187.47
Purchase	91	188.19
Purchase	9	188.19
Purchase	6	188.6
Purchase	43	187.47
Purchase	7	187.47
Purchase	70	187.89
Purchase	30	187.89
Purchase	100	187.94
Purchase	100	187.85
Purchase	100	187.87
Purchase	18	188.01
Purchase	82	188.01
Purchase	35	187.87
Purchase	100	187.87
Purchase	100	187.74
Purchase	100	187.84
Purchase	35	186.13
Purchase	22	187.91
Purchase	78	187.91
Purchase	100	187.94
Purchase	200	187.39
Purchase	100	187.74
Purchase	100	187.32
Purchase	56	187.45
Purchase	100	187.89
Purchase	100	187.86
Purchase	100	187.84
Purchase	87	187.72
Purchase	13	187.72
Purchase	100	187.81
Purchase	100	187.99
Purchase	100	187.59
Purchase	100	187.98
Purchase	100	187.96
Purchase	100	187.95
Purchase	5	187.8
Purchase	722	187.39
Purchase	25	187.85
Purchase	25	187.85
Purchase	50	187.85
Purchase	100	187.92
Purchase	100	187.66
Purchase	100	187.66
Purchase	100	187.91
Purchase	10	187.84
Purchase	90	187.84
Purchase	2	187.39
Purchase	112	187.39
Purchase	147	187.39
Purchase	271	187.39
Purchase	46	187.39
Purchase	1	187.39
Purchase	3	187.39
Purchase	99	187.75
Purchase	1	187.75
Purchase	100	187.92
Purchase	100	187.84
Purchase	100	187.81
Purchase	100	187.84
Purchase	4	186.7
Purchase	2	187.8
Purchase	13	187.53
Purchase	87	187.53
Purchase	100	186.9
Purchase	100	187.39
Purchase	71	188.65
Purchase	45	187.03
Purchase	62	187.03
Purchase	45	187.91
Purchase	67	187.94
Purchase	13	187.94
Purchase	3,536	187.39
Sale	54	187.39
Sale	100	187.82
Sale	100	187.54
Sale	100	187
Sale	100	187
Sale	100	188.32
Sale	40	188.32
Sale	100	186.69
Sale	43	188.63
Sale	57	188.63
Sale	100	188.96
Sale	100	186.93
Sale	100	186.89
Sale	822	186.7
Sale	100	188.94
Sale	47	187.04
Sale	100	187.64
Sale	100	188.7
Sale	9	187.27
Sale	13	187.27
Sale	25	187.27
Sale	38	187.27
Sale	15	187.27
Sale	1	187.39
Sale	100	187.67
Sale	23	187.868
Total Purchases	11,590
Total Sales	2,487

(b)      Derivatives transactions (other than options transactions)

Product name, e.g. CFD	Nature of transaction (Note 6)	Number of relevant securities (Note 7)	Price per unit USD (Note 5)

(c)      Options transactions in respect of existing relevant securities

(i)       Writing, selling, purchasing or varying

Product name, e.g. call option	Writing, selling, purchasing, varying etc.	Number of securities to which the option relates (Note 7)	Exercise price	Type, e.g. American, European etc.	Expiry date	Option money paid/received per unit (Note 5)

(ii)      Exercising

Product name, e.g. call option	Number of securities	Exercise price per unit (Note 5)

(d)      Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction (Note 8)	Details	Price per unit (if applicable) (Note 5)

Ap21

2.       OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing

and any other person relating to the voting rights of any relevant securities under any option

referred to on this form or relating to the voting rights or future acquisition or disposal of any 

relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9)                                            Yes

Date of disclosure	21/04/2020
Contact name	Société Générale - Disclosure team
Telephone number	+33 1 42 14 92 74
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection (Note 10)

Ap23

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL 

ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name, e.g. call option	Written, or purchased	Number of relevant securities to which the option or derivative relates	Exercise price (Note 2)	Type, e.g. American, European etc.	Expiry date
Listed Put Option	Sale	40,000	175	American options	15/01/2021
Listed Put Option	Sale	18,500	190	American options	15/01/2021

Notes

1.          Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2.          For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the 

Rules. If in doubt, consult the Panel.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

ISESEASAFESSESL